In short
Thermo Fisher Scientific Inc. (TMO) has revenue up 3.9% to $44.6B and net income up 5.8% to $6.7B year on year. Its net margin is 15.0%, and it trades at 36.8× trailing earnings. Fisclear found no medium- or high-severity risk flags in this filing. How we calculate this
Valuation
HealthcareLive · Yahoo FinancePrice
$669.54
$248.1B
23.4x
0.28%
52-Week Range
Decision Context
The reverse DCF implies growth expectations well above historical averages. Fundamentals need to accelerate significantly to justify the current price. Consider the margin of safety before sizing a position.
Based on filing period ending Sept 2026
FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.
Macro Context
Fed Funds Rate
3.88%
Accommodative
10-Year Treasury
5.13%
2026-10-01
Unemployment
4.2%
Near full employment
CPI Index
336.3
2026-09-01
M2 Money Supply
$23.4T
2026-09-01
The Federal Funds rate stands at 3.88% — a moderately elevated rate environment that raises borrowing costs across the economy; 10-year Treasury yields are at 5.13%, setting the benchmark for long-term corporate borrowing; Unemployment stands at 4.2%; Industrial production index is at 104.0; M2 money supply is $23.4T; CPI index stands at 336.3.
SWOT Analysis — TMO
Inflationary BoomStrengths
Total Assets: $110.3B (+13.4% YoY) — Total assets grew 13% — the company's resource base expanded.
EPS (Diluted): $17.74 (+7.3% YoY) — Earnings per share rose 7% — each share earned more.
Net Income: $6.7B (+5.8% YoY) — Profit grew 6% — the company kept more of each dollar earned.
Weaknesses
Operating Cash Flow: $7.8B (-9.8% YoY) — Operating cash flow fell 10% but remained positive.
Stock is near its 52-week high (712.17) — the price reflects strong recent momentum, but entry risk is elevated at these levels.
Opportunities
Revenue: $44.6B (+3.9% YoY) — Revenue grew 4% — the company sold more goods or services than the prior year.
Threats
No significant threats flagged.
Year-over-Year Changes
Total Assets
$110.3B
was $97.3B
Total assets grew 13% — the company's resource base expanded.
Operating Cash Flow
$7.8B
was $8.7B
Operating cash flow fell 10% but remained positive.
EPS (Diluted)
$17.74
was $16.53
Earnings per share rose 7% — each share earned more.
Net Income
$6.7B
was $6.3B
Profit grew 6% — the company kept more of each dollar earned.
Revenue
$44.6B
was $42.9B
Revenue grew 4% — the company sold more goods or services than the prior year.
Risk Flags
0 high · 0 medium · 1 low- ○ Low
Stock is near its 52-week high (712.17) — the price reflects strong recent momentum, but entry risk is elevated at these levels.
Technical Signals
Daily closes · 1-year dataThermo Fisher Scientific Inc.: common questions
Is Thermo Fisher Scientific Inc. profitable?
Yes. Thermo Fisher Scientific Inc. made a net profit of $6.7B in its latest fiscal year (fiscal 2025), a net margin of 15.0%.
Is Thermo Fisher Scientific Inc.'s revenue growing?
Yes. Revenue grew 3.9% year on year, to $44.6B.
What is Thermo Fisher Scientific Inc.'s P/E ratio?
Thermo Fisher Scientific Inc. trades at 35.3× its trailing twelve-month earnings. In other words, the share price is about 35 times the profit per share the company earned over the past year.
Does Thermo Fisher Scientific Inc. pay a dividend?
Yes. Thermo Fisher Scientific Inc.'s forward dividend yield is 0.28%, the expected annual dividend as a share of the current share price.
Answers are generated from the figures in this report (updated 5 Nov 2026). Information, not investment advice.
Latest News
via FinnhubFiling History — TMO
Get the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Trade TMO
Links open broker research pages. Not an endorsement or recommendation.
Research Thermo Fisher Scientific Inc.
Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.